Screening for type 2 diabetes in patients with a history of gestational diabetes Nutritional, Metabolic, Endocrine
Conditions
Interventions
Participants will be sent a HbA1c blood testing kit in the post to do at home rather than attending an in-person clinic appointment. The home blood test involves using a small handheld needle device t
Sponsors
University of Edinburgh
Eligibility
Sex/Gender
Female
Age
16 Years to 55 Years
Inclusion criteria
Inclusion criteria: 1. Aged 16 to 55 years 2. Under the care of NHS Lothian 3. Diagnosed with Gestational Diabetes this pregnancy as per NHS Lothian guidelines 4. Deemed suitable for postpartum HbA1c testing by the clinical team 5. Able to speak/read/understand a language for which translated documents can be obtained by the research team
Exclusion criteria
Exclusion criteria: 1. Aged under 16 years old 2. Classified as an Adult with Incapacity (AWI) as determined by the clinical or research team 3. Deemed unsuitable for postpartum HbA1c testing by the clinical team 4. Unable to speak/read/understand a language for which translated documents can be obtained by the research team
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The proportion of total trial participants who return their completed home HbA1c test to the lab for analysis and receive their HbA1c test result, therefore completing postnatal type 2 diabetes screening. Assessed between 13-16 weeks following the end of pregnancy for each participant; final outcome calculated upon trial completion. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Participant satisfaction with the home HbA1c screening test used for postpartum type 2 diabetes screening, measured using quantitative and qualitative participant survey data at 13-16 weeks following the end of pregnancy for each participant 2. Participant views regarding optimising postnatal screening for type 2 diabetes following a diagnosis of gestational diabetes, collected via participant survey data at 13-16 weeks following the end of pregnancy for each participant 3. The number of patients approached for recruitment into the trial, subsequent trial recruitment rates and reasons participants not recruited, collected via trial pre-screening log at trial completion | — |
Countries
Scotland, United Kingdom
Contacts
Public ContactRebecca Reynolds
Outcome results
None listed